Therefore, we further investigated the expression of TPX2 in HCC subgroups divided by TP53 mutation status and found significantly higher expression of TPX2 in TP53-mutated tumor samples than that in TP53-non-mutated samples (Fig. 6B). This evidence concerns the gene TPX2 and hepatocellular carcinoma.